NEW RESOURCES AND SURVEILLANCE GUIDES TO SUPPORT EARLY DETECTION OF PANCREATIC CANCER Pancare Foundation disseminates material commissioned by Cancer Australia and developed by UQ and Uni of Melbourne
With
Dr Michael KC Lee,
Medical Oncologist,
Peter MacCallum Cancer Centre
Dr Mark Buzza,
Head of Research, Innovation and Advocacy,
Pancare Foundation
SEGMENT
Filmed in Melbourne | February 2026
Pancreatic cancer remains one of Australia’s deadliest cancers, with five-year survival rates hovering at just 14%, with little improvement over several decades. Often called the ‘silent killer’, the disease frequently presents with minimal or vague symptoms, resulting in late diagnoses and poor outcomes. Pancare Foundation is leading the rollout of new clinical resources and surveillance guides to support healthcare professionals in identifying at-risk patients and promoting early detection.
More than 4,500 Australians are diagnosed with pancreatic cancer each year, and the disease is projected to become the second leading cause of cancer-related death by 2030. Despite advances in treatment, the lack of a population-level national screening program, as there is for bowel cancer for example, means that healthcare professionals play a critical role in early detection and patient education.
“Early identification is key,” said Dr Mark Buzza, Head of Research, Innovation and Advocacy, Pancare Foundation. “These new resources provide practical guidance for clinicians on risk assessment, surveillance protocols, and patient communication. By equipping healthcare professionals with the latest evidence-based tools, we can improve detection rates and ultimately patient outcomes.”
The resources highlight key risk factors to be aware of including a family history of pancreatic cancer, smoking, long-term diabetes, chronic pancreatitis, heavy alcohol use, and obesity.
Importantly, pancreatic cancer can also occur in patients without obvious risk factors. Developed by the University of Queensland (alongside their contributors), the new surveillance guides offer clear recommendations for monitoring high-risk individuals, identifying early symptoms, and coordinating referral pathways for diagnostic investigations.
In addition, the University of Melbourne provides pain and palliative care education resources for healthcare professionals, ensuring clinicians are equipped to support patients throughout the continuum of care.
Source: Adapted from Pancare Foundation media release
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Unleashing the potential of Paramedic skills and knowledge
According to a prominent paramedicine academic and researcher, paramedics have the potential to provide much-needed care in the community, changing the traditional healthcare model. Research points to paramedics having a wider healthcare workforce impact based on their ability to identify and fix problems 24/7.
Dr. Brendan Shannon is Head of Postgraduate Programs in the Department of Paramedicine at Monash University and a member of The Australasian College of Paramedicine. His interests including refining healthcare models, to ensure underserved communities receive requisite care. These alternative care pathways, like outreach programs, can work out of hospitals to provide care in underserved communities with social and complex chronic conditions.
